A simple prognostic score based on troponin and presepsin for COVID-19 patients admitted to the emergency department: a single-center pilot study Presepsin and Troponin in ED triage for COVID-19 patients.

Main Article Content

Paola Dell'Aquila
Pasquale Raimondo
Daniele Orso
Paola De Luca
Pietro Pozzessere
Carmen Vita Parisi
Tiziana Bove
Luigi Vetrugno
Salvatore Grasso
Vito Procacci


COVID-19; acute respiratory failure; prognostic; biomarkers; presepsin.


Background: The need to determine prognostic factors that can predict a particularly severe or, conversely, the benign course of COVID-19 is particularly perceived in the Emergency Department (ED), considering the scarcity of resources for a conspicuous mass of patients. The aim of our study was to identify some predictors for 30-day mortality among some clinical, laboratory, and ultrasound variables in a COVID-19 patients population.

Methods: Prospective single-center pilot study conducted in an ED of a University Hospital. A consecutive sample of confirmed COVID-19 patients with acute respiratory failure was enrolled from March 8th to April 15th, 2020.

Results: 143 patients were enrolled. Deceased patients (n = 65) were older (81 vs. 61 years, p <0.001), and they had more frequently a history of heart disease, neurological disease, or chronic obstructive pulmonary disease (p-values = 0.026, 0.025, and 0.034, respectively) than survived patients. Troponin I and presepsin had a significant correlation with a worse outcome. Troponin achieved a sensitivity of 77% and a specificity of 82% for a cut-off value of 27.6 ng/L. The presepsin achieved a sensitivity of 54% and a specificity of 92% for a cut-off value of 871 pg/mL.

Conclusion: In a population of COVID-19 patients with acute respiratory failure in an ED, presepsin and troponin I are accurate predictors of 30-day mortality. Presepsin is highly specific and could permit the early identification of patients who could benefit from more intensive care as soon as they enter the ED. Further validation studies are needed to confirm this result.


Download data is not yet available.
Abstract 399 | PDF Downloads 232


1. Wee LE, Fua TP, Chua YY, Ho AFW, Sim XYJ, Conceicao EP, Venkatachalam I, Tan KB, Tan BH. Containing COVID-19 in the Emergency Department: The Role of Improved Case Detection and Segregation of Suspect Cases. Acad Emerg Med. 2020 May;27(5):379-387. doi: 10.1111/acem.13984. Epub 2020 May 11. PMID: 32281231; PMCID: PMC7262126.
2. Vincent JL, Creteur J. Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds. Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):248-252. doi: 10.1177/2048872620922788. Epub 2020 Apr 29. PMID: 32347745; PMCID: PMC7196891.
3. Leclerc T, Donat N, Donat A, Pasquier P, Libert N, Schaeffer E, D'Aranda E, Cotte J, Fontaine B, Perrigault PF, Michel F, Muller L, Meaudre E, Veber B. Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources. Anaesth Crit Care Pain Med. 2020 Jun;39(3):333-339. doi: 10.1016/j.accpm.2020.05.008. Epub 2020 May 17. PMID: 32426441; PMCID: PMC7230138.
4. Jones RP. Would the United States Have Had Too Few Beds for Universal Emergency Care in the Event of a More Widespread Covid-19 Epidemic? Int J Environ Res Public Health. 2020 Jul 19;17(14):5210. doi: 10.3390/ijerph17145210. PMID: 32707674; PMCID: PMC7399859.
5. Van Singer M, Brahier T, Ngai M, Wright J, Weckman AM, Erice C, Meuwly JY, Hugli O, Kain KC, Boillat-Blanco N. COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department. J Allergy Clin Immunol. 2020 Oct 9:S0091-6749(20)31401-9. doi: 10.1016/j.jaci.2020.10.001. Epub ahead of print. PMID: 33045281; PMCID: PMC7546666.
6. Booth AL, Abels E, McCaffrey P. Development of a prognostic model for mortality in COVID-19 infection using machine learning. Mod Pathol. 2020 Oct 16:1–10. doi: 10.1038/s41379-020-00700-x. Epub ahead of print. PMID: 33067522; PMCID: PMC7567420.
7. Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X, Zhou X. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020 Jun;127:104370. doi: 10.1016/j.jcv.2020.104370. Epub 2020 Apr 14. PMID: 32344321; PMCID: PMC7194648.
8. Goodacre S, Thomas B, Lee E, Sutton L, Loban A, Waterhouse S, Simmonds R, Biggs K, Marincowitz C, Schutter J, Connelly S, Sheldon E, Hall J, Young E, Bentley A, Challen K, Fitzsimmons C, Harris T, Lecky F, Lee A, Maconochie I, Walter D. Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study. Emerg Med J. 2020 Dec 3:emermed-2020-210528. doi: 10.1136/emermed-2020-210528. Epub ahead of print. PMID: 33273040; PMCID: PMC7716294
9. Goodacre S, Thomas B, Lee E, Sutton L, Loban A, Waterhouse S, Simmonds R, Biggs K, Marincowitz C, Schutter J, Connelly S, Sheldon E, Hall J, Young E, Bentley A, Challen K, Fitzsimmons C, Harris T, Lecky F, Lee A, Maconochie I, Walter D. Characterisation of 22445 patients attending UK emergency departments with suspected COVID-19 infection: Observational cohort study. PLoS One. 2020 Nov 25;15(11):e0240206. doi: 10.1371/journal.pone.0240206. PMID: 33237907; PMCID: PMC7688143.
10. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096. PMID: 32219357; PMCID: PMC7364333.
11. Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020 Jul;194:105921. doi: 10.1016/j.clineuro.2020.105921. Epub 2020 May 15. PMID: 32422545; PMCID: PMC7227498
12. Dell’Aquila P, Raimondo P, De Matteis S, Pistone A, De Luca P, Grasso S, Procacci V. Lung ultrasound Score and management strategies in the critically COVID-19 patients. Italian Journal of Emergency Medicine 2020; 9: 126-130.
13. Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin M, El-Mowafy M, El-Mesery M, Ellythy A, Duchesne J, Killackey MT, Ferdinand KC, Kandil E, Fawzy MS. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysis. J Med Virol. 2020 Nov;92(11):2473-2488. doi: 10.1002/jmv.26166. Epub 2020 Jul 6. PMID: 32530509; PMCID: PMC7307124.
14. Aboughdir M, Kirwin T, Abdul Khader A, Wang B. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review. Viruses. 2020 May 11;12(5):527. doi: 10.3390/v12050527. PMID: 32403242; PMCID: PMC7290838.
15. Weidmann MD, Ofori K, Rai AJ. Laboratory Biomarkers in the Management of Patients With COVID-19. Am J Clin Pathol. 2020 Oct 27:aqaa205. doi: 10.1093/ajcp/aqaa205. Epub ahead of print. PMID: 33107558; PMCID: PMC7665296.
16. Attanasio F, Carrer P, Zurlo A, Rossi A, Babuin L, Mion MM, Zaninotto M, Plebani M, Iliceto S, Manzato E, Giantin V. Prognostic value of cardiac troponin I assay in hospitalized elderly patients. Aging Clin Exp Res. 2019 Feb;31(2):233-239. doi: 10.1007/s40520-018-0965-2. Epub 2018 May 4. PMID: 29728985.
17. Napoli AM, Corl K, Gardiner F, Forcada A. Prognostic value of noninvasive measures of contractility in emergency department patients with severe sepsis and septic shock undergoing early goal-directed therapy. J Crit Care. 2011 Feb;26(1):47-53. doi: 10.1016/j.jcrc.2010.05.003. Epub 2010 Jun 19. PMID: 20646897.
18. Montazer SH, Jahanian F, Khatir IG, Bozorgi F, Assadi T, Pashaei SM, Sazgar M, Mousavi SJ, Yekta AS. Prognostic Value of Cardiac Troponin I and T on Admission in Mortality of Multiple Trauma Patients Admitted to the Emergency Department: a Prospective Follow-up Study. Med Arch. 2019 Feb;73(1):11-14. doi: 10.5455/medarh.2019.73.11-14. PMID: 31097852; PMCID: PMC6445627.
19. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950. PMID: 32211816; PMCID: PMC7097841.
20. Deng P, Ke Z, Ying B, Qiao B, Yuan L. The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19. Clin Chim Acta. 2020 Nov;510:186-190. doi: 10.1016/j.cca.2020.07.018. Epub 2020 Jul 16. PMID: 32681933; PMCID: PMC7363604.
21. Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Mancini DM, Fuster V; Mount Sinai COVID Informatics Center. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020 Aug 4;76(5):533-546. doi: 10.1016/j.jacc.2020.06.007. Epub 2020 Jun 8. PMID: 32517963; PMCID: PMC7279721.
22. Artifoni M, Danic G, Gautier G, Gicquel P, Boutoille D, Raffi F, Néel A, Lecomte R. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z. PMID: 32451823; PMCID: PMC7246965.
23. Li Y, Zhao K, Wei H, Chen W, Wang W, Jia L, Liu Q, Zhang J, Shan T, Peng Z, Liu Y, Yan X. Dynamic relationship between D-dimer and COVID-19 severity. Br J Haematol. 2020 Jul;190(1):e24-e27. doi: 10.1111/bjh.16811. Epub 2020 Jun 9. PMID: 32420615; PMCID: PMC7276819.
24. Klouche K, Cristol JP, Devin J, Gilles V, Kuster N, Larcher R, Amigues L, Corne P, Jonquet O, Dupuy AM. Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care. 2016 Dec;6(1):59. doi: 10.1186/s13613-016-0160-6. Epub 2016 Jul 7. PMID: 27389015; PMCID: PMC4936977.
25. Venugopalan DP, Pillai G, Krishnan S. Diagnostic Value and Prognostic Use of Presepsin Versus Procalcitonin in Sepsis. Cureus. 2019 Jul 16;11(7):e5151. doi: 10.7759/cureus.5151. PMID: 31523578; PMCID: PMC6741385.
26. Yang HS, Hur M, Yi A, Kim H, Lee S, Kim SN. Prognostic value of presepsin in adult patients with sepsis: Systematic review and meta-analysis. PLoS One. 2018 Jan 24;13(1):e0191486. doi: 10.1371/journal.pone.0191486. PMID: 29364941; PMCID: PMC5783380.
27. Jereb M, Mavric M, Skvarc M, Drobnic A, Dolenc S, Strunjas NP, Luksic B, Kmet NG. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice. J Infect Dev Ctries. 2019 Nov 30;13(11):1038-1044. doi: 10.3855/jidc.11764. PMID: 32087076.
28. Zhao J, Tan Y, Wang L, Shi Y. Discriminatory ability and prognostic evaluation of presepsin for sepsis-related acute respiratory distress syndrome. Sci Rep. 2020 Jun 4;10(1):9114. doi: 10.1038/s41598-020-66121-7. PMID: 32499573; PMCID: PMC7272415.
29. Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013 Oct 20;17(5):R244. doi: 10.1186/cc13070. PMID: 24138799; PMCID: PMC4056322.
30. Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgrò S, Fanizza C, Romero M, Tognoni G, Latini R, Gattinoni L; ALBIOS Study Investigators. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care. 2014 Jan 7;18(1):R6. doi: 10.1186/cc13183. PMID: 24393424; PMCID: PMC4056046.
31. Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, Orihara Y, Kawamura R, Takeuchi S, Maesaki S, Maeda T. Presepsin as a predictive biomarker of severity in COVID-19: A case series. J Med Virol. 2020 Jun 12:10.1002/jmv.26164. doi: 10.1002/jmv.26164. Epub ahead of print. PMID: 32530491; PMCID: PMC7307131.
32. Zaninotto M, Mion MM, Cosma C, Rinaldi D, Plebani M. Presepsin in risk stratification of SARS-CoV-2 patients. Clin Chim Acta. 2020 Aug;507:161-163. doi: 10.1016/j.cca.2020.04.020. Epub 2020 Apr 22. PMID: 32333860; PMCID: PMC7175898.
33. Schirinzi A, Cazzolla AP, Lovero R, Lo Muzio L, Testa NF, Ciavarella D, Palmieri G, Pozzessere P, Procacci V, Di Serio F, Santacroce L. New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract. Microorganisms. 2020 Nov 2;8(11):1718. doi: 10.3390/microorganisms8111718. PMID: 33147871; PMCID: PMC7692217.
34. Ferrando-Vivas P, Doidge J, Thomas K, Gould DW, Mouncey P, Shankar-Hari M, Young JD, Rowan KM, Harrison DA; ICNARC COVID-19 Team. Prognostic Factors for 30-Day Mortality in Critically Ill Patients With Coronavirus Disease 2019: An Observational Cohort Study. Crit Care Med. 2020 Oct 28. doi: 10.1097/CCM.0000000000004740. Epub ahead of print. PMID: 33116052.
35. Venturini S, Orso D, Cugini F, Crapis M, Fossati S, Callegari A, Pellis T, Tonizzo M, Grembiale A, Rosso A, Tamburrini M, D’Andrea N, Vetrugno L, Bove T. Classification and analysis of outcome predictors in non-critically ill COVID-19 patients. Internal Medicine Journal 2020 [accepted].
36. Copetti R, Amore G, Di Gioia CC, Orso D. First comes the A, then the B: what we learned from the COVID-19 outbreak. Eur J Intern Med. 2020 Oct;80:108-110. doi: 10.1016/j.ejim.2020.06.031. Epub 2020 Jun 28. PMID: 32620500; PMCID: PMC7321044.
37. Vetrugno L, Bove T, Orso D, Bassi F, Boero E, Ferrari G. Lung Ultrasound and the COVID-19 "Pattern": Not All That Glitters Today Is Gold Tomorrow. J Ultrasound Med. 2020 Nov;39(11):2281-2282. doi: 10.1002/jum.15327. Epub 2020 May 8. PMID: 32383793; PMCID: PMC7272952.

Most read articles by the same author(s)

1 2 > >>